Patent assignee · DE · UNIVERSITY

RUPRECHT - KARLS - UNIVERSITÄT HEIDELBERG

92Patents
88Active
92Granted
54Portfolio score

Filing activity: Jul 9, 1998 → Jun 6, 2023 · 14 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8476418B2 Modified AAV capsid polypeptides Chemistry; Metallurgy 42 Active
US8369925B2 Method to derive anatomical and/or pathological structures from data of imaging technologies Performing Operations; Transporting 28 Active
US7342717B1 Wave field microscope with detection point spread function Physics 25 Expired
US7122179B2 Live genetically attenuated malaria vaccine Emerging Cross-Sectional Technologies 13 Expired
US6424421B1 Method and devices for measuring distances between object structures Physics 10 Expired
US10398791B2 Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Chemistry; Metallurgy 10 Active
US10471160B2 Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Chemistry; Metallurgy 9 Active
US10016519B2 18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Chemistry; Metallurgy 7 Active
US8414883B2 Parvovirus cancer therapy and combination with chemotherapy Chemistry; Metallurgy 6 Active
US10024986B2 Neutron detector unit and neutron detector arrangement Electricity 6 Active
US11045564B2 Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer Chemistry; Metallurgy 6 Active
US10501756B2 Gene-therapy vectors for treating cardiomyopathy Chemistry; Metallurgy 5 Active
US10393762B2 Means and methods for diagnosing heart failure in a subject Physics 4 Active
US10815200B2 18F—tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer Chemistry; Metallurgy 4 Active
US8968750B2 Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other C2-domain containing proteins Emerging Cross-Sectional Technologies 4 Active
US8876408B2 Optical connectors and a method of production thereof Emerging Cross-Sectional Technologies 3 Active
US9169283B2 Post-synthetic modification of nucleic acids by inverse diels-alder reaction Chemistry; Metallurgy 3 Active
US9464995B2 FIB-SEM array tomography Physics 3 Active
US9700588B2 Use of parvovirus for eliminating cancer stem cells (CSCs) Chemistry; Metallurgy 2 Active
US9198966B2 B-type plexin antagonists and uses thereof Chemistry; Metallurgy 2 Active
US10315975B2 Method for the hydroformylation of 2-substituted butadienes and the production of secondary products thereof, especially ambrox Chemistry; Metallurgy 2 Active
US10624935B2 Parvovirus formulation for treating tumors Human Necessities 2 Active
US9446099B2 Method for brain cancer therapy by co-administration of a parvovirus and interferon-gamma Chemistry; Metallurgy 2 Active
US10058591B2 Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer Human Necessities 2 Active
US9861669B2 Oncolytic virotherapy for prevention of tumor recurrence Chemistry; Metallurgy 2 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.